3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
13
Stomach Neoplasms
12
Colorectal Neoplasms
8
Breast Neoplasms
8
Esophageal Neoplasms
7
Rectal Neoplasms
6
Lung Neoplasms
6
Carcinoma, Hepatocellular
6
Glioblastoma
5
Brain Neoplasms
5
Neoplasms
4
Neoplasm Metastasis
4
Colonic Neoplasms
4
Cholangiocarcinoma
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Ovarian Neoplasms
3
Lymphatic Metastasis
3
Glioma
3
Endometrial Neoplasms
3
Disease
3
Astrocytoma
3
Thyroid Neoplasms
2
Recurrence
2
Pain, Postoperative
2
Oropharyngeal Neoplasms
2
Melanoma
2
Laryngeal Neoplasms
2
Gliosarcoma
2
Gastrointestinal Stromal Tumors
2
Interventions
Bupivacaine
4
Analgesia
4
Ropivacaine
3
Morphine
3
Ketamine
3
Sufentanil
2
Psychiatric Rehabilitation
2
Oxycodone
2
Methadone
2
Lidocaine
2
Ketorolac
2
Hydromorphone
2
Fentanyl
2
Esketamine
2
Epinephrine
2
Docetaxel
2
Dexmedetomidine
2
Control Groups
2
Acetaminophen
2
ziconotide
1
tanezumab
1
parecoxib
1
nabiximols
1
loxoprofen
1
Whole Body Imaging
1
Vertebroplasty
1
Tramadol
1
Therapeutics
1
Telemedicine
1
Surveys and Questionnaires
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Pain
×
Surgical Procedures, Operative
×
Clear all
NCT04086394
2020-02-20
PECS
Main Line Health
Phase NA
Unknown
130 enrolled